Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,878 | 32 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $627.12 | 7 | $0 (2022) |
| Lilly USA, LLC | $370.94 | 5 | $0 (2024) |
| AbbVie, Inc. | $316.53 | 6 | $0 (2019) |
| Dexcom, Inc. | $165.61 | 2 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $137.56 | 2 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $134.98 | 3 | $0 (2021) |
| Abbott Laboratories | $49.07 | 3 | $0 (2024) |
| Ascensia Diabetes Care US Inc. | $21.96 | 1 | $0 (2017) |
| Amgen Inc. | $21.79 | 1 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $20.38 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $145.45 | 2 | Lilly USA, LLC ($124.45) |
| 2023 | $124.37 | 1 | Lilly USA, LLC ($124.37) |
| 2022 | $134.20 | 2 | Novo Nordisk Inc ($121.88) |
| 2021 | $260.04 | 3 | Novo Nordisk Inc ($233.61) |
| 2020 | $243.35 | 4 | Lilly USA, LLC ($122.12) |
| 2019 | $339.35 | 4 | Dexcom, Inc. ($123.00) |
| 2018 | $314.25 | 4 | Novartis Pharmaceuticals Corporation ($117.22) |
| 2017 | $317.25 | 12 | AbbVie, Inc. ($115.18) |
All Payment Transactions
32 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/31/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $124.45 | General |
| Category: Obesity | ||||||
| 04/03/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Neuromodulation | ||||||
| 05/10/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $124.37 | General |
| Category: Diabetes | ||||||
| 10/11/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.32 | General |
| Category: Cardiovascular | ||||||
| 09/14/2022 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $121.88 | General |
| Category: Diabetes | ||||||
| 12/07/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Diabetes | ||||||
| 11/04/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $108.61 | General |
| Category: Diabetes | ||||||
| 02/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: RESPIRATORY | ||||||
| 08/26/2020 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $121.23 | General |
| Category: Diabetes | ||||||
| 03/03/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $96.15 | General |
| 03/03/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $16.35 | General |
| 03/03/2020 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $9.62 | General |
| 10/23/2019 | Dexcom, Inc. | DEXCOM CGM (Device) | Food and Beverage | In-kind items and services | $123.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/27/2019 | Abbott Laboratories | FreeStyle Libre (Device) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Diabetes Care | ||||||
| 06/06/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $108.75 | General |
| Category: Diabetes | ||||||
| 04/23/2019 | AbbVie, Inc. | — | Food and Beverage | In-kind items and services | $92.51 | General |
| 07/31/2018 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $88.19 | General |
| Category: DIABETES | ||||||
| 07/12/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Endocrinology | ||||||
| 04/11/2018 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $99.45 | General |
| Category: Endocrinology | ||||||
| 04/03/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $117.22 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/07/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $1.80 | General |
| Category: Endocrinology | ||||||
| 08/18/2017 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $12.98 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 06/20/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $20.34 | General |
| Category: CARDIOVASCULAR | ||||||
| 06/12/2017 | AbbVie, Inc. | Synthroid (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: Endocrinology | ||||||
| 05/16/2017 | Novo Nordisk Inc | Xultophy 100/3.6 (Drug) | Food and Beverage | In-kind items and services | $23.97 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,602 | 3,902 | $668,121 | $310,349 |
| 2022 | 26 | 2,837 | 4,388 | $739,781 | $327,426 |
| 2021 | 35 | 3,062 | 4,725 | $846,510 | $376,572 |
| 2020 | 35 | 3,189 | 4,556 | $782,714 | $324,239 |
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 472 | 906 | $175,764 | $83,103 | 47.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 490 | 490 | $132,300 | $66,875 | 50.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 204 | 580 | $125,280 | $49,609 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 223 | 287 | $35,301 | $16,757 | 47.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 93 | 114 | $30,552 | $16,500 | 54.0% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 143 | 266 | $40,432 | $15,756 | 39.0% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 71 | 95 | $25,555 | $12,006 | 47.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 163 | 166 | $18,260 | $11,927 | 65.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Office | 2023 | 51 | 55 | $16,995 | $8,393 | 49.4% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 28 | 28 | $9,968 | $7,902 | 79.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 167 | 170 | $6,460 | $5,449 | 84.3% |
| 99316 | Nursing facility discharge management, more than 30 minutes | Office | 2023 | 22 | 23 | $4,278 | $2,538 | 59.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 219 | 290 | $10,150 | $2,436 | 24.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 50 | 55 | $9,075 | $2,294 | 25.3% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 13 | 13 | $4,433 | $2,271 | 51.2% |
| 93793 | Anticoagulant management of patient taking warfarin | Office | 2023 | 20 | 176 | $6,336 | $1,626 | 25.7% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Office | 2023 | 40 | 46 | $4,692 | $1,525 | 32.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 35 | 35 | $1,330 | $1,122 | 84.3% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 11 | $1,925 | $764.71 | 39.7% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 15 | 21 | $2,709 | $704.20 | 26.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 50 | 52 | $4,992 | $572.62 | 11.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 22 | 23 | $1,334 | $218.96 | 16.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 522 | 981 | $190,314 | $90,286 | 47.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 460 | 460 | $124,200 | $64,039 | 51.6% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Office | 2022 | 213 | 660 | $142,560 | $48,315 | 33.9% |
About Dr. Angelo Miele, MD
Dr. Angelo Miele, MD is a Internal Medicine healthcare provider based in Carol Stream, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144326109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Angelo Miele, MD has received a total of $1,878 in payments from pharmaceutical and medical device companies, with $145.45 received in 2024. These payments were reported across 32 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($1,878).
As a Medicare-enrolled provider, Miele has provided services to 11,690 Medicare beneficiaries, totaling 17,571 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Carol Stream, IL
- Active Since 09/16/2006
- Last Updated 06/24/2016
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1144326109
Products in Payments
- RYBELSUS (Drug) $354.84
- Synthroid (Drug) $222.22
- ENTRESTO (Drug) $137.56
- ZEPBOUND (Drug) $124.45
- MOUNJARO (Drug) $124.37
- DEXCOM CGM (Device) $123.00
- Rybelsus (Drug) $121.88
- Ozempic (Drug) $108.75
- JARDIANCE (Drug) $108.55
- Dexcom G5 Mobile CGM System (Device) $42.61
- STIOLTO RESPIMAT (Drug) $26.43
- Xultophy 100/3.6 (Drug) $23.97
- CONTOUR NEXT ONE Meter (Device) $21.96
- Corlanor (Drug) $21.79
- PROCLAIM (Device) $21.00
- SOLIQUA (Drug) $20.38
- FreeStyle Libre (Device) $15.09
- CardioMEMS HF System (Device) $12.98
- ELIQUIS (Drug) $12.32
- Androgel (Drug) $1.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Carol Stream
Nausheen Hasan, M.d, M.D
Internal Medicine — Payments: $10,761
Susan Ignatius, Md, MD
Internal Medicine — Payments: $3,055
Lawrence Schouten, Md, MD
Internal Medicine — Payments: $1,441
Mark Bednard, Do, DO
Internal Medicine — Payments: $1,380
Asad Rafiq, Md, MD
Internal Medicine — Payments: $1,271
Evelyn Diaz-Jimenez, M.d, M.D
Internal Medicine — Payments: $437.60